Expert Consensus on Tumor Cell Reduction Surgery Combined with Intraperitoneal Hyperthermic Chemotherapy for Pseudomyxoma Peritonei
2022-08-26
A Controlled Study of Intracavitary Constant Temperature Circulating Thermal Perfusion Chemotherapy for Malignant Pleural Effusion - Wang Liufei 2010 (Li Wei)
2022-08-26
Thermal Chemotherapy for Tumors - Current Status and Prospects
Drug treatment for tumors, commonly known as chemotherapy, is currently one of the main methods for treating tumors. With the increasing incidence of malignant tumors, research in related fields is very active worldwide. The emergence of new drugs and the standardization and improvement of chemotherapy regimens have led to a certain degree of improvement in the survival rate and survival time of cancer patients.
2022-08-26
Clinical Analysis of Malignant Chest and Abdominal Cavity Hyperthermic Intraperitoneal Chemotherapy
Malignant pleural and abdominal effusion is one of the common clinical manifestations and serious complications of malignant tumors. Any malignant tumor can cause malignant pleural and abdominal effusion when it invades the thoracic or abdominal cavity. The treatment of malignant pleural and abdominal effusion can be divided into systemic and local treatment methods. For malignant tumors that are sensitive or relatively sensitive to chemotherapy, systemic chemotherapy can lead to malignant pleural effusion.
2022-08-26
In the past two years, the use of constant temperature circulating perfusion for intraperitoneal and venous double-route hyperthermic chemotherapy has achieved satisfactory results in preventing and treating intraperitoneal metastatic cancer, which cannot be achieved by non-circulating hyperthermic perfusion chemotherapy. This article analyzes and compares the mechanisms, feasibility, treatment methods, and efficacy of intraperitoneal circulating and non-circulating hyperthermic perfusion chemotherapy based on clinical observations and literature reports.
2022-08-26